Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device

Organon (NYSE: OGN) received FDA acceptance to review a supplemental New Drug Application for its hormone free contraceptive ...

Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears

Compass Pathways (NASDAQ:CMPS) said it expects to complete its rolling New Drug Application submission for its synthetic ...

Onco360® is a participating specialty pharmacy in the ZENBEXUS™ (iberdomide) limited dispense network

Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected as a participating pharmacy by Bristol-Myers Squibb for ZENBEXUS™ (iberdomide), indicated, in combination with ...
American Hospital Association

SAMHSA awards $42 million to states, territories for ‘Treatment First’ addiction assistance

The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support addiction programs using the new ...